Search

The purpose of this essay is to explore the implications of #metoo and #aidtoo for understanding nonprofit/nongovernmental organization (NPO/NGO) theory and practice. We provide an overview of how women have experienced sexual violence in the context of NPOs/NGOs and draw on an intersectional feminist theory lens to highlight the context that enables violence to persist, and which requires more than implementing bureaucratic accountability reforms. We end by discussing potential avenues for creating change to end such violence.

The purpose of this study is to understand feminist empowerment through the grant-making and other work of U.S. women's foundations and funds to determine how they incorporate and facilitate empowerment. This study contributes new knowledge on the connections between feminist empowerment theories and the organizational practices of women's philanthropic organizations. To assess the ways in which empowerment manifests in the work of these organizations, feminist empowerment literature was examined along with development literature on women's empowerment, and critiques of empowerment. For this study, a database was created of more than 200 foundations and funds in 43 states by using website and IRS data and a survey administered. The findings speak to the ways in which women's foundations and funds align with empowerment theories and the areas of disconnect. [ABSTRACT FROM AUTHOR]

Background: Measuring clinically relevant opioid-related problems in health care systems is challenging due to the lack of standard definitions and coding practices. Well-defined, opioid-related health problems (ORHPs) would improve prevalence estimates and evaluation of clinical interventions, crisis response, and prevention activities. We sought to estimate prevalence of opioid use disorder (OUD), opioid misuse, and opioid poisoning among inpatients at a large, safety net, health care institution. Methods: Our study included events documented in the electronic health records (EHRs) among hospitalized patients at Denver Health Medical Center during January 1, 2017 to December 31, 2018. Multiple EHR markers (ie, opioid-related diagnostic codes, clinical assessment, laboratory results, and free-text documentation) were used to develop diagnosis-based and extended definitions for OUD, opioid misuse, and opioid poisoning. We used these definitions to estimate number of hospitalized patients with these conditions. Results: During a 2-year study period, 715 unique patients were identified solely using opioid-related diagnostic codes; OUD codes accounted for the largest proportion (499/715, 69.8%). Extended definitions identified an additional 973 unique patients (~136% increase), which includes 155/973 (15.9%) who were identified by a clinical assessment marker, 1/973 (0.1%) by a laboratory test marker, and 817/973 (84.0%) by a clinical documentation marker. Conclusions: Solely using diagnostic codes to estimate prevalence of clinically relevant ORHPs missed most patients with ORHPs. More inclusive estimates were generated using additional EHR markers. Improved methods to estimate ORHPs among a health care system's patients would more fully estimate organizational and economic burden to more efficiently allocate resources and ensure capacity to provide clinical services. [ABSTRACT FROM AUTHOR]